Free tool
Healthcare stocks
We cover 64 companies in the Healthcare sector. The median market value in the group is $1.23B. Across the group, the median move over the past trading day is +0.55%. 60% of the 60 with a 200-day average trade above it. Price change over the past year runs from −37.5% to +75.7% across the middle 80 percent of the group, with a median of −4.3%.
Other lists in this group
Table
64 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% | Oct 27, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% | Oct 14, 2026 |
| DAP.DE | Danaher Corporation | 184.45 EUR | +4.06% | −5.68% | +6.90% | Oct 20, 2026 |
| IUI1.DE | Intuitive Surgical, Inc. | 318.75 EUR | +1.95% | −33.01% | −21.06% | Oct 20, 2026 |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% | Sep 1, 2026 |
| A58.DE | Elevance Health, Inc. | 342.50 EUR | +2.03% | +13.81% | −19.30% | Oct 21, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 194.20 EUR | +13.30% | −7.09% | +11.32% | Oct 22, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% | Oct 27, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | 195.00 EUR | +9.92% | +0.74% | +21.79% | Oct 22, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% | Sep 21, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% | Sep 17, 2026 |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% | Sep 23, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% | Sep 10, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% | Oct 22, 2026 |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% | Oct 20, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% | Oct 22, 2026 |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% | Sep 10, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% | Oct 16, 2026 |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% | Oct 22, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% | Sep 24, 2026 |
| IVA.PA | Inventiva S.A. | 4.09 EUR | +3.94% | +0.99% | −14.63% | Sep 25, 2026 |
| TTALO.HE | Terveystalo Oyj | 7.78 EUR | +4.29% | −16.20% | −22.31% | Oct 21, 2026 |
| VETO.PA | Vetoquinol SA | 70.60 EUR | −3.29% | −16.35% | −6.37% | Sep 11, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% | Oct 22, 2026 |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% | Oct 23, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% | Sep 23, 2026 |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% | Sep 29, 2026 |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% | Oct 22, 2026 |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −1.02% | −24.08% | −25.98% | Sep 28, 2026 |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% | Sep 8, 2026 |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% | Sep 29, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% | Sep 29, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| ALCGM.PA | Cegedim SA | 10.26 EUR | +1.38% | −25.92% | −4.56% | Sep 24, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% | Oct 22, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% | Sep 28, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% | Oct 22, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% | Aug 28, 2026 |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% | Oct 22, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% | Sep 10, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% | Sep 15, 2026 |
| 6IV.DE | Inventiva S.A. | 4.08 EUR | +3.68% | +0.87% | −33.03% | Sep 25, 2026 |
| ADXN.SW | Addex Therapeutics Ltd | 0.03 CHF | −37.38% | −51.32% | −55.21% | Sep 14, 2026 |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% | Oct 23, 2026 |
| MOVE.SW | Medacta Group SA | 127.40 CHF | −7.55% | −18.95% | −10.60% | Sep 9, 2026 |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% | Oct 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.